Physician
Hematology
Dr. Saul E. Rivkin, MD
|
|
Give Review
Saul Rivkin works in the field of Hematology. He researched medicine at University Hospital - University of Cincinnati College of Medicine. Dr. Saul E. Rivkin has written publications. He has 14 publications published with PubMed. The lastest paper is: 'Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.'
Publications
- Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.
- Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergro...
- Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intraVenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy ...
- External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Onco...
- Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
- A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study.
- Randomized, controlled trial of cyclophosphamide, methotrexate, and fluorouracil versus cyclophosphamide, doxorubicin, and fluorouracil with and without tamoxifen for ...
- Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levami...
- Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
- A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin Lymphoma: Southwest Oncology Grou...
- Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patie...
- SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group study.
- Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-Cell lung cancer.
Schools
University Of Washington School Of Medicine
University Hospital
Conditions Treated
- Acute Leukemia
- Anemia
- Deep Vein Thrombosis (DVT)
- Hodgkin's Disease
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
University Hospital - University of Cincinnati College of Medicine -
University of Washington School of Medicine
Hospital
-
Swedish Medical Center-Cherry Hill Campus
Helpful Reviews
Similar Doctors
|
|
Dr. Andrei R. Shustov, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John M. Harlan, MD |
|
|
Dr. Gerald J. Roth, MD |
|
|
Dr. Mary Philip, MD |
|
|
Dr. Raya Mawad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel E. Sabath, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Pamela S. Becker, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Weiqiang Gao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Konstantinos G. Balotis, MD |
|
|
Dr. Daniel N. Egan, MD |
|
|
Dr. Tejaswini M. Dhawale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy R. Haley, MD |
|
|
Dr. Melinda A. Biernacki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Kennedy, MD |
|
|
Dr. Hirohisa Nakamae, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Dian-Kun Li, MD |
|
|
Dr. Michael W. Schmitt, MD |
|
|
Maria G. Salvatierra |
|
|
Dr. Yap-Yee Chong, MD |